Juan A. Aceves-Hernandez

Mexico, MEX, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells.

Pulmonarom® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells.

Journal: Frontiers in cellular and infection microbiology

Published: May 26, 2026

Wnt3a-expressing cancer stem cells impair CD8+ TRM function, contributing to immunotherapy resistance in Melanoma.

Wnt3a-expressing cancer stem cells impair CD8+ TRM function, contributing to immunotherapy resistance in Melanoma.

Journal: Oncoimmunology

Published: December 04, 2025

Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal Neurocysticercosis.

Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal Neurocysticercosis.

Journal: ACS infectious diseases

Published: August 18, 2025

Novel Oral papaya-based preventive and therapeutic vaccine for controlling different zoonotic Taeniid parasites: Current advances.

Novel Oral papaya-based preventive and therapeutic vaccine for controlling different zoonotic Taeniid parasites: Current advances.

Journal: Vaccine

Published: July 03, 2025

Neuroimmune-Endocrine Modulation of T-Cell Exhaustion in Central Nervous System Parasitic Diseases: Insights from Toxoplasmosis and Neurocysticercosis.

Neuroimmune-Endocrine Modulation of T-Cell Exhaustion in Central Nervous System Parasitic Diseases: Insights from Toxoplasmosis and Neurocysticercosis.

Journal: Neuroimmunomodulation

Published: July 01, 2025

Immunomodulatory Effects of Pulmonarom®: In Vitro Induction of TLR and Cytokine Expression in Human Dendritic Cells.

Immunomodulatory Effects of Pulmonarom®: In Vitro Induction of TLR and Cytokine Expression in Human Dendritic Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 14, 2025

In silico, in vitro and in vivo toxicity assessment of the antitumoral peptide GK-1.

In silico, in vitro and in vivo toxicity assessment of the antitumoral peptide GK-1.

Journal: Toxicology reports

Published: December 28, 2024

Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model.

Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model.

Journal: Vaccine

Published: September 16, 2024

Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial.

Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial.

Journal: Archives of medical research

Published: July 15, 2023

GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model.

GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model.

Journal: Cancer immunology, immunotherapy : CII

Published: June 15, 2023

Standardizing an Experimental Murine Model of Extraparenchymal Neurocysticercosis That Immunologically Resembles Human Infection.

Standardizing an Experimental Murine Model of Extraparenchymal Neurocysticercosis That Immunologically Resembles Human Infection.

Journal: Brain sciences

Published: May 17, 2023

Increased TNF-α production in response to IL-6 in patients with systemic inflammation without infection.

Increased TNF-α production in response to IL-6 in patients with systemic inflammation without infection.

Journal: Clinical and experimental immunology

Published: December 21, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026